Telmisartan to Irbesartan Conversion
When converting from telmisartan to irbesartan, use a 1:3.75 ratio: telmisartan 40 mg converts to irbesartan 150 mg, and telmisartan 80 mg converts to irbesartan 300 mg.
Dose Equivalency
The FDA-approved dosing ranges provide the framework for conversion 1:
- Telmisartan: 20-80 mg once daily (usual starting dose 40 mg)
- Irbesartan: 150-300 mg once daily
Based on the standard therapeutic doses used in clinical practice and research:
- Telmisartan 40 mg → Irbesartan 150 mg
- Telmisartan 80 mg → Irbesartan 300 mg
This conversion ratio is consistently supported across multiple comparative studies 2, 3, 4, 5 where telmisartan 40-80 mg was directly compared with irbesartan 150-300 mg as equipotent antihypertensive doses.
Clinical Considerations
Blood pressure monitoring is essential after conversion 1. The antihypertensive effect reaches maximum reduction after 4 weeks with telmisartan, so reassess blood pressure at 2-4 weeks post-conversion.
Important Differences Between These ARBs
While both are effective antihypertensives, telmisartan demonstrates superior metabolic effects:
- Telmisartan acts as a partial PPARγ agonist, while irbesartan has minimal PPARγ activity 3, 4, 5
- In diabetic patients, telmisartan produces greater improvements in insulin resistance (HOMA-IR decreased 29% vs increased 16% with irbesartan) 2
- Telmisartan increases adiponectin more effectively via PPARα activation 6
A recent 2024 network meta-analysis found telmisartan and olmesartan demonstrated the best balance of efficacy and safety among ARBs 7, suggesting you may want to reconsider whether switching away from telmisartan is necessary.
Practical Switching Protocol
- Stop telmisartan and start irbesartan the next day (no washout needed)
- Use the conversion ratios above based on current telmisartan dose
- Monitor blood pressure at 2 weeks and 4 weeks post-conversion
- Titrate irbesartan to 300 mg if blood pressure control is inadequate at 150 mg